Company Profile

149 Medical Inc
Profile last edited on: 1/30/2020      CAGE: 81CV8      UEI: P3CACVT5FJG6

Business Identifier: Medical device to reduce potential disability in preterm newborns patients
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1173 Main Street
Bolton, MA 01740
Location: Single
Congr. District: 03
County: Worcester

Public Profile

There is currently no device/technology that allows for continuous monitoring of brain hemodynamics (blood flow and metabolism) - a deficiency that is particularly crucial in the neonatal ICU where long term negative outcomes such as cerebral palsy and intellectual disability are driven by injuries to the brain due to the immature cardiovascular system and under-/over-treatment. Intended to to reduce disability in preterm newborns patients, the device being developed by 149 Medical is designed to be the first non-invasive monitor that measures real-time brain hemodynamics and metabolism, second by second. The system provides early actionable alerts and continuous feedback allowing for early intervention and treatment monitoring.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Antoniu Fantana -- Co-Founder, President and CEO

  Bernhard Zimmermann -- Co-Founder

Company News

There are no news available.